Showing results (271-280 of 6,006) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|May 1, 2008
Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP miceKomal Raina, Subapriya Rajamanickam, Gagan Deep, et al.
Molecular Cancer Therapeutics|April 1, 2008
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changesRonald A Lubet, Eva Szabo, Konstantin Christov, et al.
Molecular Cancer Therapeutics|April 1, 2008
Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levelsCatherine A Tucker, Anita I Kapanen, Ghania Chikh, et al.
Molecular Cancer Therapeutics|April 3, 2025
Target-Specific Locked Nucleic Acid Gapmer Decreases Growth and Metastases of Pancreatic CancerJill P Smith, Narayan Shivapurkar, Wenqiang Chen, et al.
Molecular Cancer Therapeutics|April 28, 2025
The anti-FRα antibody-drug conjugate luveltamab tazevibulin demonstrates efficacy in non-small cell lung cancer preclinical models and induces immunogenic cell deathRobert Yuan, Andrew McGeehan, Sihong Zhou, et al.
Molecular Cancer Therapeutics|April 16, 2025
HER1 (EGFR) and/or HER2 inclusion potentiates the antitumor effect elicited by a HER3-specific monovalent vaccineErnesto Bermúdez-Abreut, Gretchen Bergado Báez, Talia Fundora-Barrios, et al.
Molecular Cancer Therapeutics|April 15, 2025
Moxidectin unravels the role of Hippo-YAP pathway in maintaining immunity of glioblastoma multiformeItishree Kaushik, Robin Rajan, Shreyas Gaikwad, et al.
Molecular Cancer Therapeutics|June 18, 2025
Antineoplastic activity of a novel tri-specific single chain antibody targeting the hERG1/β1 integrin complex and TRAIL receptorsClaudia Duranti, Jessica Iorio, Chiara Capitani, et al.
Molecular Cancer Therapeutics|June 4, 2025
Optimization of a Novel 2 + 2 BCMA × CD3 Bispecific Antibody for Minimized Cytokine Release and Potent EfficacyDanqing Wu, Lini Huang, Gaowa Naren, et al.
Molecular Cancer Therapeutics|May 29, 2025
Colony-Stimulating Factor-1 Receptor Inhibitor Augments Osimertinib-Induced Antitumor Immunity via Suppression of Macrophages in Lung Cancer Harboring EGFR MutationSachi Okawa, Shuta Tomida, Tadahiro Kuribayashi, et al.
Pageof 601